Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 1283-1285, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Cao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Cao, H.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 1999;45:1283-1285.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Mannose-binding Lectin Gene Variation and Cardiovascular Disease in Canadian Inuit

Robert A. Hegele1,a, Christopher P. Busch1, T. Kue Young2, Philip W. Connelly3 and Henian Cao1

1 Robarts Research Institute and Department of Medicine, University of Western Ontario, London, Ontario, Canada N6A 5K8;
2 Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada R3E OW2;
3 Departments of Medicine and Biochemistry, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada M5B 1A6;
a address correspondence to this author at: Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406-100 Perth Dr., London, Ontario, Canada N6A 5K8: fax 519-663-3789, e-mail robert.hegele@rri.on.ca

Canadian Inuit have an age-adjusted mortality from cardiovascular disease that is ~40% lower than the rest of Canada (1). This might result from the protective influence of certain environmental factors, such as the consumption of Arctic fish (1) or of certain genetic factors. For example, the thermolabile variant of the MTHFR gene, which encodes methylenetetrahydrofolate reductase, is one-sixth as prevalent in Inuit than in subjects of European origin (2). However, there are some inconsistent genetic findings in these people. For example, genetic variants that are associated with an increased risk of cardiovascular disease, such as the E4 allele of the APOE gene and the T235 allele of the AGT gene, are significantly more prevalent in Inuit than in whites (3). The resolution of such inconsistencies may come from the fact that several genes likely determine susceptibility to cardiovascular disease (4). It will thus be necessary to evaluate newer genetic determinants of cardiovascular disease risk in the Inuit.

One possible new genetic determinant for cardiovascular risk is the common coding sequence variation in the MBL gene, which encodes mannose-binding lectin (MBL) (5). MBL is an innate immune defense protein that binds mannose and other sugars on the surface of a variety of infectious agents, thereby facilitating phagocytosis and activation of the complement cascade (6)(7). MBL likely modulates the severity of infection with Chlamydia pneumoniae (6)(7), a pathogen linked by several lines of experimentation to the initiation and propagation of atherosclerosis (8). This might explain the association of genetic variation in MBL with severe atherosclerosis (5).

There are three common polymorphic sites in MBL. The Gly->Asp variant at MBL codon 54 (G54D) in exon 1, also . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
CirculationHome page
L. G. Best, M. Davidson, K. E. North, J. W. MacCluer, Y. Zhang, E. T. Lee, B. V. Howard, S. DeCroo, and R. E. Ferrell
Prospective Analysis of Mannose-Binding Lectin Genotypes and Coronary Artery Disease in American Indians: The Strong Heart Study
Circulation, February 3, 2004; 109(4): 471 - 475.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. A Albert, N. Rifai, and P. M Ridker
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis
Vascular Medicine, August 1, 2001; 6(3): 145 - 149.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.